These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 25620535

  • 21. Dissociation of endocrine responses to the Trier Social Stress Test in Virtual Reality (VR-TSST) by the benzodiazepine alprazolam and the translocator protein 18 kDa (TSPO) ligand etifoxine.
    Bahr LM, Maurer F, Weigl J, Weber K, Melchner D, Dörfelt A, Wechsler TF, Bauer O, Reinders J, Milenkovic VM, Wetzel CH, Wetter TC, Rupprecht R, Mühlberger A, Nothdurfter C.
    Psychoneuroendocrinology; 2021 Feb; 124():105100. PubMed ID: 33338971
    [Abstract] [Full Text] [Related]

  • 22. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M.
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [Abstract] [Full Text] [Related]

  • 23. Etifoxine impairs neither alertness nor cognitive functions of the elderly: A randomized, double-blind, placebo-controlled crossover study.
    Deplanque D, Machuron F, Waucquier N, Jozefowicz E, Duhem S, Somers S, Colin O, Duhamel A, Bordet R.
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):925-932. PubMed ID: 30135030
    [Abstract] [Full Text] [Related]

  • 24. A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder.
    Mahableshwarkar AR, Jacobsen PL, Serenko M, Chen Y.
    Hum Psychopharmacol; 2014 Jan; 29(1):64-72. PubMed ID: 24424707
    [Abstract] [Full Text] [Related]

  • 25. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM.
    J Int Med Res; 1980 Dec; 8(2):139-43. PubMed ID: 6102940
    [Abstract] [Full Text] [Related]

  • 28. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, Barnhill J.
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [Abstract] [Full Text] [Related]

  • 29. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.
    Pecknold J, Luthe L, Munjack D, Alexander P.
    J Clin Psychopharmacol; 1994 Oct; 14(5):314-21. PubMed ID: 7806686
    [Abstract] [Full Text] [Related]

  • 30. An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression.
    Imlah NW.
    Br J Psychiatry; 1985 May; 146():515-9. PubMed ID: 2861873
    [Abstract] [Full Text] [Related]

  • 31. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E, Patterson W, Rickels K, Rosenthal M.
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
    Weisler RH, Greenbaum M, Arnold V, Yu M, Yan B, Jaffee M, Robertson B.
    CNS Drugs; 2017 Aug; 31(8):685-697. PubMed ID: 28712074
    [Abstract] [Full Text] [Related]

  • 33. [Cross-sectional study of the prevalence of adjustment disorder with anxiety in general practice].
    Semaan W, Hergueta T, Bloch J, Charpak Y, Duburcq A, Le Guern ME, Alquier C, Rouillon F.
    Encephale; 2001 Aug; 27(3):238-44. PubMed ID: 11488254
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of lesopitron in outpatients with generalized anxiety disorder.
    Fresquet A, Sust M, Lloret A, Murphy MF, Carter FJ, Campbell GM, Marion-Landais G.
    Ann Pharmacother; 2000 Feb; 34(2):147-53. PubMed ID: 10676820
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.
    Depress Anxiety; 2008 Feb; 25(3):182-9. PubMed ID: 17311303
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
    Frattola L, Garreau M, Piolti R, Bassi S, Albizzati MG, Borghi C, Morselli PL.
    Br J Psychiatry; 1994 Jul; 165(1):94-100. PubMed ID: 7802852
    [Abstract] [Full Text] [Related]

  • 37. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Enkelmann R.
    Psychopharmacology (Berl); 1991 Jul; 105(3):428-32. PubMed ID: 1798836
    [Abstract] [Full Text] [Related]

  • 38. An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action.
    Nuss P, Ferreri F, Bourin M.
    Neuropsychiatr Dis Treat; 2019 Jul; 15():1781-1795. PubMed ID: 31308671
    [Abstract] [Full Text] [Related]

  • 39. Differential effects of the translocator protein 18 kDa (TSPO) ligand etifoxine and the benzodiazepine alprazolam on startle response to predictable threat in a NPU-threat task after acute and short-term treatment.
    Brunner LM, Maurer F, Weber K, Weigl J, Milenkovic VM, Rupprecht R, Nothdurfter C, Mühlberger A.
    Psychopharmacology (Berl); 2022 Jul; 239(7):2233-2244. PubMed ID: 35278124
    [Abstract] [Full Text] [Related]

  • 40. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH, Tiller J, Xie F, Trivedi MH.
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.